Abstract
Oxidative stress is thought to play a role in the onset of dementia. HIV-dementia has recently been demonstrated to be associated with oxidative stress as indexed by increased protein and lipid peroxidation in the brain and cerebrospinal fluid compared to HIV non-demented patients. The HIV protein Tat induces neurotoxicity, and, more recently, Tat was found to induce oxidative stress directly and indirectly. The role of Tat in HIV-dementia and possible therapeutic strategies involving endogenous and exogenous antioxidants are discussed.
Original language | English |
---|---|
Pages (from-to) | 14-26 |
Number of pages | 13 |
Journal | Brain Research Reviews |
Volume | 50 |
Issue number | 1 |
DOIs | |
State | Published - Dec 1 2005 |
Bibliographical note
Funding Information:This work was supported in part by grants from NIH (MH64409; AG-10836; AG-05119) to D.A.B. and (RO1 NS39253; P20 RR15592) to A.N.
Keywords
- Antioxidant
- HIV-dementia
- Oxidative stress
- Tat
ASJC Scopus subject areas
- General Neuroscience
- Clinical Neurology